CLAVENTIN Side Effects

6992865-4 | Burning Sensation, Cheilitis, Cholestasis, Confusional State, Eosinophilia, Erythema, Eyelid Oedema
on Sep 07, 2010 Female patient from FRANCE , 86 years of age, was treated with Claventin (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, cheilitis, cholestasis, confusional state, eosinophilia, erythema, eyelid oedema. Claventin dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), TAVANIC (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6068698-2 | Agranulocytosis, Eosinophilia, Erythema, Haemodynamic Instability, Pyrexia, Rash, Rash Pustular, Sepsis
Patient was taking Claventin (View Usage). Patient had the following side effects: agranulocytosis, eosinophilia, erythema, haemodynamic instability, pyrexia, rash (What is rash?), rash pustular, sepsis (What is sepsis?) on Jan 28, 2009 from FRANCE Additional patient health information: Male patient , 20 years of age, was diagnosed with sedation and. Claventin dosage: . During the same period patient was treated with NEBCIN (View Nebcin Review and Nebcin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

5946525-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatocellular Injury
Adverse event was reported on Oct 30, 2008 by a Male patient taking Claventin (View Usage) (Dosage: 5g Three Times Per Day) . Location: FRANCE , 47 years of age, After Claventin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatocellular injury. During the same period patient was treated with TRIFLUCAN (400mg Twice Per Day) (View Triflucan Review and Triflucan Label ), ZYVOXID (600mg Twice Per Day) (View Zyvoxid Review and Zyvoxid Label ), TIENAM (View Tienam Review and Tienam Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (1g Three Times Per Day) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), ARIXTRA (7.5mg Per Day) (View Arixtra Review and Arixtra Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5765489-4 | C-reactive Protein Increased, Dyspnoea, Lymphopenia, Oxygen Saturation Decreased, Prurigo, Pyrexia, Rash Erythematous
on May 29, 2008 Female patient from FRANCE , 64 years of age, was treated with Claventin (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, dyspnoea, lymphopenia, oxygen saturation decreased, prurigo, pyrexia, rash erythematous. Claventin dosage: 5g Three Times Per Day. During the same period patient was treated with FORTUM (2g Three Times Per Day) (View Fortum Review and Fortum Label ), BACTRIM (400mg Twice Per Day) (View Bactrim Review and Bactrim Label ), REVLIMID (25mg Per Day) (View Revlimid Review and Revlimid Label ), ZOMETA (4mg Per Day) (View Zometa Review and Zometa Label ), LOXEN LP 50 MG (50mg Twice Per Day) (View Loxen Lp 50 Mg Review and Loxen Lp 50 Mg Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), OXYGENE (View Oxygene Review and Oxygene Label ). Patient was hospitalized.


5705735-6 | Renal Failure Chronic, Staphylococcal Infection, Urticaria
on Apr 04, 2008 Female patient from FRANCE , 77 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Claventin (View Usage). Patient had the following side effects: renal failure chronic, staphylococcal infection (What is staphylococcal infection?), urticaria. Claventin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), NEXIUM (View Nexium Review and Nexium Label ), FOSFOMYCINE (View Fosfomycine Review and Fosfomycine Label ), TARGOCID (View Targocid Review and Targocid Label ).

5602534-0 | Dizziness Postural, Erythema, Oedema Peripheral, Pain, Pruritus, Rash Papular, Rash Pustular, Scab
Patient was taking Claventin (View Usage). After Claventin was administered, patient had the following side effects: dizziness postural, erythema, oedema peripheral, pain (What is pain?), pruritus, rash papular, rash pustular, scab (What is scab?) on Jan 14, 2008 from FRANCE Additional patient health information: Female patient , 70 years of age, . Claventin dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), RIFADIN (300mg Twice Per Day) (View Rifadin Review and Rifadin Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

5492009-4 | Alkalosis, Hypokalaemia
Adverse event was reported on Oct 10, 2007 by a Female patient taking Claventin (View Usage) (Dosage: 5g Three Times Per Day) was diagnosed with osteitis and. Location: FRANCE , 72 years of age, Patient experienced the following unwanted or unexpected effects: alkalosis, hypokalaemia. During the same period patient was treated with CIFLOX (View Ciflox Review and Ciflox Label ), CALCIPARINE (View Calciparine Review and Calciparine Label ), GENTALLINE (View Gentalline Review and Gentalline Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), LOVENOX (View Lovenox Review and Lovenox Label ), TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (View Tramadol Hydrochloride And Acetaminophen Review and Tramadol Hydrochloride And Acetaminophen Label ), VENOFER (View Venofer Review and Venofer Label ).

5492009-4 | Alkalosis, Hypokalaemia
on Oct 10, 2007 Female patient from FRANCE , 72 years of age, was diagnosed with osteitis and was treated with Claventin (View Usage). Patient had the following side effects: alkalosis, hypokalaemia. Claventin dosage: 5g Three Times Per Day. During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), CALCIPARINE (View Calciparine Review and Calciparine Label ), GENTALLINE (View Gentalline Review and Gentalline Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), LOVENOX (View Lovenox Review and Lovenox Label ), TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (View Tramadol Hydrochloride And Acetaminophen Review and Tramadol Hydrochloride And Acetaminophen Label ), VENOFER (View Venofer Review and Venofer Label ).

5365554-X | Acne, Purpura, Skin Disorder, Skin Fragility, Skin Lesion, Toxic Skin Eruption
on Jun 12, 2007 Male patient from FRANCE , 54 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Claventin (View Usage). After Claventin was administered, patient had the following side effects: acne (What is acne?), purpura, skin disorder, skin fragility, skin lesion, toxic skin eruption. Claventin dosage: 5g Three Times Per Day. During the same period patient was treated with ERLOTINIB (100mg Per Day) (View Erlotinib Review and Erlotinib Label ), OMEPRAZOLE (50mg Per Day) (View Omeprazole Review and Omeprazole Label ), OFLOCET (200mg Twice Per Day) (View Oflocet Review and Oflocet Label ). Patient was hospitalized.

5302117-6 | Anaemia Macrocytic, Blood Lactate Dehydrogenase Increased, Coombs Test Positive, Haemolytic Anaemia, Haptoglobin Decreased
Patient was taking Claventin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia macrocytic, blood lactate dehydrogenase increased, coombs test positive, haemolytic anaemia, haptoglobin decreased on Apr 12, 2007 from FRANCE Additional patient health information: Female patient , 69 years of age, was diagnosed with pseudomonas infection and. Claventin dosage: 600mg Per Day. During the same period patient was treated with OROCAL (View Orocal Review and Orocal Label ), OFLOCET (View Oflocet Review and Oflocet Label ), LANTUS (View Lantus Review and Lantus Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TOPALGIC ( FRANCE ) (View Topalgic ( France ) Review and Topalgic ( France ) Label ), FORLAX (View Forlax Review and Forlax Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), LANSOYL (View Lansoyl Review and Lansoyl Label ). Patient was hospitalized.

5278615-0 | Biopsy Kidney Abnormal, Blood Creatinine Increased, Renal Failure Acute, Urinary Retention
Adverse event was reported on Mar 22, 2007 by a Male patient taking Claventin (View Usage) (Dosage: ) was diagnosed with hyperthermia, hypertension, acute myeloid leukaemia and. Location: FRANCE , 60 years of age, Patient had the following side effects: biopsy kidney abnormal, blood creatinine increased, renal failure acute, urinary retention. During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), TARGOCID (View Targocid Review and Targocid Label ), NISIS (View Nisis Review and Nisis Label ), VFEND (View Vfend Review and Vfend Label ), ZOPHREN (8mg Per Day) (View Zophren Review and Zophren Label ), ARACYTINE (400mg Per Day) (View Aracytine Review and Aracytine Label ), CERUBIDINE (120mg Per Day) (View Cerubidine Review and Cerubidine Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

5275773-9 | Face Oedema, Perivascular Dermatitis, Rash Maculo-papular, Skin Burning Sensation, Skin Exfoliation
on Mar 22, 2007 Female patient from FRANCE , 60 years of age, was diagnosed with lung abscess and was treated with Claventin (View Usage). After Claventin was administered, patient had the following side effects: face oedema, perivascular dermatitis, rash maculo-papular, skin burning sensation, skin exfoliation. Claventin dosage: 1g Three Times Per Day. During the same period patient was treated with TILDIEM (60mg Per Day) (View Tildiem Review and Tildiem Label ), FLAGYL (500mg Three Times Per Day) (View Flagyl Review and Flagyl Label ), ROCEPHIN (2g Per Day) (View Rocephin Review and Rocephin Label ), NOVOMIX (View Novomix Review and Novomix Label ). Patient was hospitalized.

5256490-8 | Face Oedema, Perivascular Dermatitis, Rash Maculo-papular, Skin Burning Sensation, Skin Exfoliation
on Feb 28, 2007 Female patient from FRANCE , 60 years of age, was diagnosed with lung abscess and was treated with Claventin (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, perivascular dermatitis, rash maculo-papular, skin burning sensation, skin exfoliation. Claventin dosage: 1g Three Times Per Day. During the same period patient was treated with TILDIEM (60mg Per Day) (View Tildiem Review and Tildiem Label ), FLAGYL (500mg Three Times Per Day) (View Flagyl Review and Flagyl Label ), ROCEPHIN (2g Per Day) (View Rocephin Review and Rocephin Label ), NOVOMIX (View Novomix Review and Novomix Label ). Patient was hospitalized.

5249856-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholestasis, Gamma-glutamyltransferase Increased
Patient was taking Claventin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased on Feb 19, 2007 from FRANCE Additional patient health information: Male patient , 56 years of age, weighting 127.9 lb, was diagnosed with lung infection, essential hypertension and. Claventin dosage: 5g Three Times Per Day. During the same period patient was treated with BACTRIM (2amp Twice Per Day) (View Bactrim Review and Bactrim Label ), TRIATEC (2.5mg Per Day) (View Triatec Review and Triatec Label ), LASIX (20mg Three Times Per Day) (View Lasix Review and Lasix Label ), OMEPRAZOLE (40mg Per Day) (View Omeprazole Review and Omeprazole Label ), LOVENOX (40mg Per Day) (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

5168230-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Cardiac Failure Congestive, Hepatic Failure, Hepatocellular Damage, Hyperkalaemia, Prothrombin Level Decreased
Adverse event was reported on Aug 03, 2006 by a Female patient taking Claventin (View Usage) (Dosage: 3g Twice Per Day) . Location: FRANCE , 57 years of age, After Claventin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatic failure, hepatocellular damage, hyperkalaemia, prothrombin level decreased. During the same period patient was treated with IMUREL (View Imurel Review and Imurel Label ). Patient was hospitalized.

5075823-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Cardiac Failure Congestive, Hepatocellular Damage, Hyperkalaemia, Prothrombin Level Decreased, Respiratory Distress
on Aug 03, 2006 Female patient from FRANCE , 57 years of age, was treated with Claventin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatocellular damage, hyperkalaemia, prothrombin level decreased, respiratory distress. Claventin dosage: 3g Twice Per Day. During the same period patient was treated with IMUREL (View Imurel Review and Imurel Label ). Patient was hospitalized.

5044497-5 | Renal Failure Acute
on Jul 04, 2006 Male patient from FRANCE , 58 years of age, weighting 121.3 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Claventin (View Usage). Patient had the following side effects: renal failure acute. Claventin dosage: 3g Four Times Per Day. During the same period patient was treated with RAPIFEN (View Rapifen Review and Rapifen Label ), LOVENOX (View Lovenox Review and Lovenox Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), CATAPRES (View Catapres Review and Catapres Label ), PLAVIX (View Plavix Review and Plavix Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), AMLOR (View Amlor Review and Amlor Label ), DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ). Patient was hospitalized.

4884864-3 | Eosinophilia, Neutropenia
Patient was taking Claventin (View Usage). After Claventin was administered, patient had the following side effects: eosinophilia, neutropenia on Dec 28, 2005 from FRANCE Additional patient health information: Female patient , 51 years of age, weighting 167.6 lb, was diagnosed with osteitis and. Claventin dosage: 3g Three Times Per Day. During the same period patient was treated with FRAXIPARINE (1inj Per Day) (View Fraxiparine Review and Fraxiparine Label ), PLAVIX (3g Three Times Per Day) (View Plavix Review and Plavix Label ), EFFERALGAN CODEINE (View Efferalgan Codeine Review and Efferalgan Codeine Label ), LANTUS (View Lantus Review and Lantus Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), DIFFU K (View Diffu K Review and Diffu K Label ), TOPALGIC ( FRANCE ) (View Topalgic ( France ) Review and Topalgic ( France ) Label ). Patient was hospitalized.

4874165-1 | Eosinophilia, Neutropenia
Adverse event was reported on Dec 28, 2005 by a Female patient taking Claventin (View Usage) (Dosage: 3g Three Times Per Day) was diagnosed with osteitis and. Location: FRANCE , 51 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, neutropenia. During the same period patient was treated with FRAXIPARINE (1inj Per Day) (View Fraxiparine Review and Fraxiparine Label ), PLAVIX (3g Three Times Per Day) (View Plavix Review and Plavix Label ), EFFERALGAN CODEINE (View Efferalgan Codeine Review and Efferalgan Codeine Label ), LANTUS (View Lantus Review and Lantus Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), DIFFU K (View Diffu K Review and Diffu K Label ), TOPALGIC ( FRANCE ) (View Topalgic ( France ) Review and Topalgic ( France ) Label ). Patient was hospitalized.

4830259-8 | Condition Aggravated, Hepatitis Cholestatic
on Nov 08, 2005 Male patient from FRANCE , 49 years of age, was treated with Claventin (View Usage). Patient had the following side effects: condition aggravated, hepatitis cholestatic. Claventin dosage: 5g Three Times Per Day. During the same period patient was treated with VIREAD (1unit Per Day) (View Viread Review and Viread Label ), MOPRAL (20mg Per Day) (View Mopral Review and Mopral Label ), BACTRIM (1unit Per Day) (View Bactrim Review and Bactrim Label ), MABTHERA (View Mabthera Review and Mabthera Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), HOLOXAN (View Holoxan Review and Holoxan Label ). Patient was hospitalized.

4543577-8 | Accidental Overdose, Anoxia, Catheter Related Infection, Cerebral Haemorrhage, Convulsion, Cytolytic Hepatitis, Haemodynamic Instability, Hyponatraemia
on May 17, 2004 Male patient from , weighting 4.41 lb, was diagnosed with necrotising colitis and was treated with Claventin (View Usage). After Claventin was administered, patient had the following side effects: accidental overdose, anoxia, catheter related infection, cerebral haemorrhage, convulsion, cytolytic hepatitis, haemodynamic instability, hyponatraemia. Claventin dosage: .